CAMK2G and cardiac hypertrophy: Additionally in genetically modified mice modelling cardiac hypertrophy through increased CaMKII activity, Wu et al. (2002) showed that transgenic ventricular myocytes had an increased LTCC open probability, compared with WT myocytes, corresponding to a high frequency of EADs and arrhythmias in the transgenic mice.